Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in gBRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer
OlympiA 研究的患者报告结局:一项针对 gBRCA1/2 突变和高危人表皮生长因子受体 2 阴性早期乳腺癌患者的奥拉帕尼辅助治疗 III 期随机、安慰剂对照试验
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.23.01214
Ganz, Patricia A; Bandos, Hanna; Španić, Tanja; Friedman, Sue; Müller, Volkmar; Kuemmel, Sherko; Delaloge, Suzette; Brain, Etienne; Toi, Masakazu; Yamauchi, Hideko; de Dueñas, Eduardo-M; Armstrong, Anne; Im, Seock-Ah; Song, Chuan-Gui; Zheng, Hong; Sarosiek, Tomasz; Sharma, Priyanka; Geng, Cuizhi; Fu, Peifen; Rhiem, Kerstin; Frauchiger-Heuer, Heike; Wimberger, Pauline; t'Kint de Roodenbeke, Daphné; Liao, Ning; Goodwin, Annabel; Chakiba-Brugère, Camille; Friedlander, Michael; Lee, Keun Seok; Giacchetti, Sylvie; Takano, Toshimi; Henao-Carrasco, Fernando; Virani, Shamsuddin; Valdes-Albini, Frances; Domchek, Susan M; Bane, Charles; McCarron, Edward C; Mita, Monica; Rossi, Giovanna; Rastogi, Priya; Fielding, Anitra; Gelber, Richard D; Scheepers, Elsemieke D; Cameron, David; Garber, Judy; Geyer, Charles E; Tutt, Andrew N J